ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,649.84
      0.33%
      US Tech 100
      19,763.20
      -0.42%
      Dow Jones
      40,783.50
      1.42%
      Brent Oil
      83.365
      -1.16%
      Bitcoin
      63,683.29
      -1.80%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      08/10/20185:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      08/07/20186:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      08/07/20186:09PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ATRSAntares Pharma Inc
      08/07/20185:00PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      08/07/20187:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/07/20187:00AMGlobeNewswire Inc.Antares Pharma Reports Second Quarter 2018 Operating and Financial ResultsNASDAQ:ATRSAntares Pharma Inc
      08/06/20184:30PMGlobeNewswire Inc.Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research & Development, Chief Medical OfficerNASDAQ:ATRSAntares Pharma Inc
      08/06/20187:00AMGlobeNewswire Inc.Antares Pharma Enters Into Development Agreement With Pfizer Inc.NASDAQ:ATRSAntares Pharma Inc
      07/31/20187:00AMGlobeNewswire Inc.Antares Pharma to Report Second Quarter 2018 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      06/20/20185:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20185:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/13/20185:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20187:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/07/20187:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/05/20185:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/05/20185:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/05/20185:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/05/20189:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/01/20185:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      05/30/20185:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      05/30/20187:00AMGlobeNewswire Inc.Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET™ Needle-Free Delivery SystemNASDAQ:ATRSAntares Pharma Inc
      05/29/20187:00AMGlobeNewswire Inc.Antares Pharma to Present at the Jefferies 2018 Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS